By Counterforce Health Team in Xospata (gilteritinib) —

Xospata (Gilteritinib) Approval with UnitedHealthcare in Virginia: Answers to the Most Common Questions

Answer Box: Getting Xospata Covered by UnitedHealthcare in Virginia

Xospata (gilteritinib) requires prior authorization from UnitedHealthcare for relapsed/refractory AML with confirmed FLT3 mutations. Fastest approval path: Submit PA with FDA-approved FLT3 test results, prior therapy documentation, and oncologist's medical necessity letter. First step today: Have your hematologist/oncologist gather FLT3 mutation testing and prior treatment records, then submit through UnitedHealthcare's provider portal. If denied, Virginia offers expedited external review for cancer treatments within 120 days.

Table of Contents

Coverage Basics

Is Xospata covered by UnitedHealthcare?

Yes, Xospata (gilteritinib) is covered as a specialty medication on UnitedHealthcare formularies, but it requires prior authorization and is typically placed in Tier 3 (highest cost-sharing tier) for commercial plans. Some UnitedHealthcare Community Plans list it as Tier 2 (Brand).

Which UnitedHealthcare plans cover Xospata?

Most UnitedHealthcare plans in Virginia cover Xospata, including:

  • Commercial employer plans
  • Individual marketplace (ACA) plans
  • Medicare Advantage plans (with step therapy requirements starting 2025)
  • Some Medicaid managed care plans

Coverage specifics vary by plan. Check your Summary of Benefits or call the member services number on your ID card to confirm.

The Approval Process

Who submits the prior authorization request?

Your hematologist or oncologist typically submits the prior authorization through UnitedHealthcare's provider portal. As the patient, you cannot submit PA requests directly, but you can follow up on status and provide additional documentation if requested.

How do I check the status of my request?

Providers can check status through the UnitedHealthcare Provider Portal using the TrackIt tool. As a patient, you can:

  • Call UnitedHealthcare member services (number on your ID card)
  • Ask your provider's office for updates
  • Request written confirmation once approved

Timing and Urgency

How long does prior authorization take?

Standard timeline: UnitedHealthcare processes most prior authorizations within 72 hours of receiving complete documentation.

Expedited review: For urgent cancer treatment needs, expedited appeals are processed within 72 hours. Your oncologist must certify that waiting could seriously jeopardize your health.

What qualifies as urgent for Xospata?

Expedited review applies when:

  • Delay could worsen your AML prognosis
  • You're experiencing rapid disease progression
  • Standard timing could compromise treatment outcomes

Your oncologist must provide clinical documentation supporting the urgent need.

Clinical Criteria

What documentation is required for approval?

Essential requirements:

  • FLT3 mutation testing: Must use FDA-approved or CLIA-compliant test showing ITD or TKD mutations
  • Relapsed/refractory status: Documentation that AML has returned after treatment or didn't respond to initial therapy
  • Age confirmation: Patient must be 18 years or older
  • Baseline ECG: Required due to QT prolongation risk

Does step therapy apply to Xospata?

For new UnitedHealthcare members: Yes, starting January 1, 2025, Medicare Advantage plans require trying preferred AML treatments first (Step 1 drugs) before covering Xospata.

Exemptions from step therapy:

  • Existing users with paid claims in past 365 days
  • Medical contraindications to preferred alternatives
  • Prior failure or intolerance to Step 1 drugs
  • Clinical documentation showing Xospata is medically necessary

Understanding Your Costs

What will I pay for Xospata?

Wholesale cost: Approximately $28,979 for a 30-day supply (90 tablets of 40mg)

Your out-of-pocket costs depend on:

  • Plan tier (Tier 2 or 3)
  • Deductible status
  • Coinsurance percentage (typically 20-50% for specialty drugs)
  • Annual out-of-pocket maximum

Cost-saving options:

Tip: Contact Astellas at 1-800-727-7003 to explore patient support programs that may reduce your costs.

Denials and Appeals

Why might Xospata be denied?

Common denial reasons:

  • Missing FLT3 mutation test results
  • Attempting to use for front-line (newly diagnosed) AML
  • Lack of prior therapy documentation
  • Non-hematology prescriber
  • Incomplete medical necessity documentation

How do I appeal a UnitedHealthcare denial?

Internal Appeals Process:

  1. Level 1 Internal Appeal
    • Timeline: Submit within 180 days of denial
    • Processing: 72 hours for expedited, 30 days for standard
    • How to submit: UnitedHealthcare Provider Portal or written request
  2. Level 2 Internal Appeal (if Level 1 denied)
    • Timeline: 60 days from Level 1 denial
    • Processing: Same timelines as Level 1

Virginia External Review:

  • When: After completing internal appeals (or immediately for cancer treatment denials)
  • Timeline: Submit within 120 days to Virginia Bureau of Insurance
  • Form: Complete External Review Request Form 216-A
  • Processing: 45 days standard, 72 hours expedited
  • Contact: Virginia Bureau of Insurance at 1-877-310-6560
Note: Virginia allows expedited external review for cancer treatment denials without exhausting internal appeals first.

Renewal Requirements

When do I need to renew prior authorization?

Most Xospata approvals are granted for 6-12 months. Your oncologist will need to submit renewal documentation showing:

  • Continued medical necessity
  • Treatment response or stable disease
  • Absence of prohibitive side effects
  • Updated lab values and imaging

What changes might affect my coverage?

  • Plan formulary updates (usually January 1st)
  • New step therapy requirements
  • Changes in FDA labeling or guidelines
  • Your clinical status or treatment response

Specialty Pharmacy

Why was my prescription transferred to a specialty pharmacy?

UnitedHealthcare requires specialty medications like Xospata to be dispensed through Optum Specialty Pharmacy or other approved specialty pharmacies. This ensures:

  • Proper handling and storage
  • Clinical support and monitoring
  • Coordination with your care team
  • Insurance processing for high-cost drugs

How does specialty pharmacy work?

  • Your prescription is automatically transferred
  • Optum Specialty contacts you to coordinate delivery
  • Medications are shipped directly to your home
  • Clinical pharmacists provide ongoing support

Troubleshooting Common Issues

What if the provider portal is down?

Alternative submission methods:

  • Fax requests to UnitedHealthcare (verify current fax number with customer service)
  • Phone prior authorization line for urgent cases
  • Mail written requests (allow extra processing time)

What if forms are missing or incomplete?

Common missing documents:

  • FLT3 mutation test report
  • Prior therapy summary with dates and outcomes
  • Current treatment plan and goals
  • Baseline ECG results

Contact your oncologist's office to ensure all required documentation is included with resubmission.

Virginia-Specific Resources

State Insurance Support

Virginia Bureau of Insurance

  • Phone: 1-877-310-6560
  • Address: P.O. Box 1157, Richmond, VA 23218
  • Services: External review assistance, consumer guidance, complaint resolution

Virginia Managed Care Ombudsman

  • Contact: Through SCC Consumer Services (same number above)
  • Services: Help with HMO and managed care plan issues

External Review Process in Virginia

Virginia provides robust consumer protections for insurance denials:

  • No cost to you for external review
  • Independent medical experts review your case
  • Binding decision on the insurance company
  • Fast timelines for urgent cases (72 hours)
  • Special cancer provision: No need to complete internal appeals first

For comprehensive guidance on getting coverage approvals for complex medications like Xospata, Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with payer requirements.

Frequently Asked Questions

Q: Can I get Xospata covered if I haven't tried other AML treatments first? A: For newly diagnosed AML, UnitedHealthcare typically requires trying standard induction therapy first. However, if you have contraindications or your oncologist documents medical necessity for front-line Xospata use, exceptions may be granted.

Q: What if my FLT3 test was done at an outside lab? A: The test must use an FDA-approved method, regardless of where it's performed. Ensure your oncologist has the complete report showing specific mutation types (ITD or TKD).

Q: How quickly can I get an expedited appeal decision? A: UnitedHealthcare processes expedited appeals within 72 hours. Virginia external review for urgent cancer cases is also decided within 72 hours.

Q: Does UnitedHealthcare cover Xospata for maintenance after stem cell transplant? A: Coverage for post-transplant maintenance use depends on clinical circumstances and may require additional documentation showing medical necessity and guideline support.

Q: What if I move from Virginia to another state? A: Your UnitedHealthcare coverage continues, but external review processes vary by state. Contact your new state's insurance department for specific appeal rights and procedures.

From our advocates: We've seen patients successfully obtain Xospata coverage even after initial denials by ensuring their oncologist includes comprehensive FLT3 testing documentation, detailed prior therapy timelines, and specific references to NCCN guidelines supporting the treatment choice. The key is thorough documentation that directly addresses the plan's specific criteria.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider about treatment decisions and contact UnitedHealthcare directly for the most current coverage policies. For personalized assistance with insurance appeals, consider consulting with patient advocacy services or legal professionals specializing in healthcare coverage.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.